ENDRA Life Sciences reports Q2 2026 net income of $160,000 on digital asset gains
ENDRA reported net income of $159,944 for the quarter ended June 30, 2026, compared with a net loss of $1,225,912 a year earlier. The result came from $1.6 million in other income, mainly digital asset gains, while total operating expenses rose to $1.5 million from $1.3 million. The company is pursuing a merger with Noble Africa LLC, which is expected to close in the fourth quarter of 2026 and would rename ENDRA Noble Africa Inc.
Key points
- Q2 2026 net income was $159,944, versus a net loss of $1,225,912 in Q2 2025.
- Total operating expenses were $1,483,256, up from $1,301,090; other income was $1.6 million, mainly from digital asset gains.
- As of June 30, 2026, cash was $1,739,943 and restricted cash was $3,800,003.
- Merger agreement with Noble Africa dated June 25, 2026; closing expected in Q4 2026, subject to stockholder and regulatory approvals.
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 17, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.